Tailor an Options Trading Strategy to Fit Your Needs
This guide will help you identify and execute an options trading strategy that fits your specific needs and risk profile.

Take your trading to the next level with the Options Strategy Guide.
Download your FREE Options Strategy Guide Today.
pixel
Katherine S. Zanotti net worth and biography

Katherine Zanotti Biography and Net Worth

Director of Exact Sciences
Katherine S. Zanotti served as Chief Executive Officer of Arbonne International from 2009 until 2018. Ms. Zanotti also served as Chair of Natural Products Group (the holding company of Arbonne, Nature's Gate, and Levlad) from 2010 until 2018 when Groupe Rocher acquired Natural Products Group and Arbonne International. Arbonne is a botanically based skin care, cosmetic and nutrition company marketed in seven countries, with revenue of over $600 million. From 2002 to 2006, she served as Senior Vice President of Marketing at McDonald's Corporation. Prior to joining McDonald's, Ms. Zanotti was a Vice President at the Procter & Gamble Company and most recently served as Vice President and General Manager of the North American pharmaceutical business and the corporate women's health platform. Ms. Zanotti currently serves on the Board of Trustees of Xavier University and as a director of Cutera, Inc., a developer of cosmetic and aesthetic laser equipment. She previously served as a director of Hill-Rom Holdings, Inc., Mentor Corporation, Alberto Culver Company, and Third Wave Technologies, Inc. Ms. Zanotti earned a bachelor's degree in economics and studio fine arts from Georgetown University and a Master of Business Administration with a concentration in marketing and finance from Xavier University. Ms. Zanotti's extensive executive, managerial and leadership experience, including many years in the pharmaceutical industry, positions her well to serve as a member of our Board. Her business acumen and experience on the boards of directors of numerous companies make her a valuable addition to our Board of Directors.

What is Katherine S. Zanotti's net worth?

The estimated net worth of Katherine S. Zanotti is at least $1.96 million as of July 26th, 2022. Ms. Zanotti owns 60,318 shares of Exact Sciences stock worth more than $1,959,732 as of September 30th. This net worth evaluation does not reflect any other investments that Ms. Zanotti may own. Learn More about Katherine S. Zanotti's net worth.

How do I contact Katherine S. Zanotti?

The corporate mailing address for Ms. Zanotti and other Exact Sciences executives is 5505 ENDEAVOR LANE, MADISON WI, 53719. Exact Sciences can also be reached via phone at (608) 284-5700 and via email at [email protected] Learn More on Katherine S. Zanotti's contact information.

Has Katherine S. Zanotti been buying or selling shares of Exact Sciences?

Within the last three months, Katherine S. Zanotti has sold $208,005.12 in Exact Sciences stock. Most recently, Katherine S. Zanotti sold 4,608 shares of the business's stock in a transaction on Tuesday, July 26th. The shares were sold at an average price of $45.14, for a transaction totalling $208,005.12. Following the completion of the sale, the director now directly owns 60,318 shares of the company's stock, valued at $2,722,754.52. Learn More on Katherine S. Zanotti's trading history.

Who are Exact Sciences' active insiders?

Exact Sciences' insider roster includes Sarah Condella (SVP), Kevin Conroy (CEO), D. Coward (Insider), James Doyle (Director), Jeffrey Elliott (CFO), Torsten Hoof (Insider), Graham Lidgard (Insider), Jacob Orville (Insider), and Katherine Zanotti (Director). Learn More on Exact Sciences' active insiders.

Are insiders buying or selling shares of Exact Sciences?

In the last twelve months, insiders at the medical research company sold shares 18 times. They sold a total of 98,337 shares worth more than $7,882,944.49. The most recent insider tranaction occured on July, 26th when Director Katherine S Zanotti sold 4,608 shares worth more than $208,005.12. Insiders at Exact Sciences own 1.3 % of the company. Learn More about insider trades at Exact Sciences.

Information on this page was last updated on 7/26/2022.

Katherine S. Zanotti Insider Trading History at Exact Sciences

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/26/2022Sell4,608$45.14$208,005.1260,318View SEC Filing Icon  
6/30/2022Sell1,086$40.13$43,581.1860,318View SEC Filing Icon  
7/30/2021Sell1,381$111.11$153,442.9134,741View SEC Filing Icon  
12/14/2020Sell20,000$132.06$2,641,200.0040,171View SEC Filing Icon  
7/28/2020Sell1,164$96.13$111,895.3241,907View SEC Filing Icon  
7/31/2019Sell1,744$117.93$205,669.9242,844View SEC Filing Icon  
2/28/2019Sell25,000$92.81$2,320,250.0094,274View SEC Filing Icon  
11/12/2018Sell7,667$69.00$529,023.00102,786View SEC Filing Icon  
4/12/2018Sell7,232$45.00$325,440.00105,814View SEC Filing Icon  
8/3/2016Buy3,380$17.93$60,603.40105,927View SEC Filing Icon  
See Full Table

Katherine S. Zanotti Buying and Selling Activity at Exact Sciences

This chart shows Katherine S Zanotti's buying and selling at Exact Sciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Exact Sciences Company Overview

Exact Sciences logo
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for breast, prostate, and colon cancers; Oncotype Test, a tissue test delivering tumor profiling to aid therapy selection for patients with advanced, metastatic, refractory, or recurrent cancer; Oncotype DX AR-V7 Nucleus Detect Test, a liquid-based test for advanced stage prostate cancer; Oncomap ExTra, that provides a complete biological picture of certain refractory, rare, or aggressive cancers; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research; and Hologic, Inc. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.
Read More

Today's Range

Now: $32.49
Low: $32.46
High: $34.51

50 Day Range

MA: $39.77
Low: $31.97
High: $49.37

2 Week Range

Now: $32.49
Low: $31.62
High: $104.50

Volume

2,276,653 shs

Average Volume

2,160,568 shs

Market Capitalization

$5.75 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.37
The Collapse of 2022 Has Begun
Almost every asset you own could be in grave danger -- stocks, bonds, real estate and even banks.

Today, Dr. Martin Weiss reveals his survival plan for these unprecedented times.

Protect your wealth now.
>>>
pixel